Topics

Companies Related to "Gene Study Yields Possible Alzheimer Target" [Most Relevant Company Matches] RSS

16:10 EDT 15th September 2019 | BioPortfolio

Here are the most relevant search results for "Gene Study Yields Possible Alzheimer Target" found in our extensive corporate database of over 50,000 company records.

Showing "Gene Study Yields Possible Alzheimer Target" Companies 1–25 of 2,200+

Relevant

Alzheon, Inc.

Alzheon, Inc., is a clinical-stage biotechnology company focused on brain health, memory and aging, developing innovative treatments for Alzheimer’s disease and other neurodegenerative disorders. Alzheon pursues drug development programs that have previously been tested in extensive efficacy studies in Alzheimer’s disease patients and where new i...


Gene Expression Technologies

Gene Expression Technologies Limited (GET) is a biopharmaceutical company established to develop and commercialise Gene ICE™, a unique and proprietary platform for gene expression regulation. This technology is being used to develop a new class of novel therapeutic agent and to facilitate GET's own programmes for drug target discovery. Gene ICE™ is also now available to pharmaceutical and biot...

Alzheimer's Research Foundation

The Fisher Center for Alzheimer's Research Foundation is a leading source of funding for Alzheimer's research. It serves Alzheimer's patients and their families to understand the causes of Alzheimer's, to discover a cure, and to improve the lives of people with the disease. Nobel laureate Dr. Paul Greengard directs the Foundation's team of internationally renowned scientists, who have been at th...


Alzheimer’s Greater Los Angeles

Alzheimer’s Greater Los Angeles (formerly known as Alzheimer’s Association, California Southland Chapter) provides programs and services free of charge to individuals with Alzheimer’s and related dementias, their families, caregivers and the community. Low cost training and education are also offered for professionals. Alzheimer’s Great...

EXPERT BIOMED, INC

Expert BioMed offers a service to pharmaceutical companies providing screening of potential drugs on Alzheimer's disease cell and animal models designed and maintained in the company and data interpretation service in addition to the Expert BioMed systems and platform for new drug development. Expert BioMed offers new monoclonal and polyclonal antibodies, recombinant proteins and peptides as bioma...

Alzheimer's Drug Discovery Foundation (ADDF)

Alzheimer's Drug Discovery Foundation (http://www.alzdiscovery.org/) is the only public charity whose sole mission is to fund drug discovery and development to prevent, treat, and cure Alzheimer's disease and cognitive aging. An affiliated public charity of the Institute for the Study of Aging (ISOA), a private foundation established by the Estee Lauder family in 1998, ADDF was established in 2004...

The Alzheimer's Association

The Alzheimer's Association is the leading voluntary health organization in Alzheimer care, support and research. Our mission is to eliminate Alzheimer's disease through the advancement of research; to provide and enhance care and support for all affected; and to reduce the risk of dementia through the promotion of brain health. Our vision is a world without Alzheimer's. For more informatio...

Alzheimer’s Orange County

Alzheimer’s Orange County provides programs and services, free of charge, to Orange County residents with Alzheimer’s and related dementia disorders, their families, caregivers, and the community. Alzheimer’s Orange County began as an independent 501c3 nonprofit in 1982, became a chapter of the national Alzheimer’s Association in 1984, and in ...

Alzheimer's Research and Prevention Foundation

The Alzheimer's Research and Prevention Foundation (ARPF) is a non-profit organization dedicated to reducing the incidence of Alzheimer's disease by conducting clinical research and providing educational outreach about the lifestyle changes that can help prevent Alzheimer's disease. For more information, please visit the Alzheimer's Research and Prevention Foundation at www.alzheimersprevention.o...

PRIMOGENIX

Primogenix was founded early in 2003 with the purpose of providing investigators around the world with access to high quality embryonic stem cells and gene targeting technology in order to further their research efforts. We are dedicated to providing researchers with the tools and technologies necessary to study gene function in animal systems.

Alzheimer’s Association, New York City Chapter

Alzheimer’s disease is one of the nation’s largest public health crises. It is the fifth leading cause of death in California and the only leading cause of death that cannot be prevented, cured or even slowed. 630,000 people in California are currently living with Alzheimer’s disease, and more than 1.6 million Californians provide unpaid care for ...

Aranesp

Aranesp® (darbepoetin alfa) is indicated for the treatment of anemia associated with chronic renal failure (CRF), including patients on dialysis and patients not on dialysis, and for the treatment of anemia in patients with nonmyeloid malignancies where anemia is due to the effect of concomitantly administered chemotherapy.Important Product Safety InformationAranesp® is contraindicated in patien...

Alzheimer's Foundation International

The Alzheimer's Foundation International (AFI) is working toward collaboratively setting a paradigm of quality care for individuals with the disease and their families by raising awareness of Alzheimer's disease and related dementias, providing education, and establishing programs and services that can be replicated in countries around the globe. Currently, AFI's member organizations are the Alzhe...

Institute for The Study of Aging

Venture philanthropy is an evolving term that has been used to describe a variety of charitable operating models. Biomedical Venture Philanthropy describes a new model that has evolved to foster drug discovery research and development. The Institute for the Study of Aging (ISOA) has adopted this model to fund drug discovery research and development for Alzheimer’s disease.Operating like a ventur...

Paradigm Genetics Incorporated

Paradigm Genetics is industrializing the process of gene function determination for four major sectors of the global economy: human health, nutrition, crop production, and industrial products. We believe that gene function rather than gene sequence will ultimately create a new paradigm in industrializing functional genomics. This belief is the key to our business, research, and patent strategy. We...

Neurologix

Neurologix, Inc., a leader in the development of innovative therapies for the brain and central nervous system, utilizes gene therapy and other novel technologies. The central nervous system ("CNS") is a new and particularly exciting target for gene therapy because its unique properties prevent the successful treatment of many neurological disorders by conventional means such as drug therapy and s...

The Alzheimer’s Association

The Alzheimer’s Association is the world’s leading voluntary health organization in Alzheimer care, support and research. Its mission is to eliminate Alzheimer’s disease through the advancement of research; to provide and enhance care and support for all affected; and to reduce the risk of dementia through the promotion of brain health. Learn more ...

Axonyx

Axonyx is a biopharmaceutical company focused on the acquisition and development of proprietary products and technologies for the treatment and diagnosis of Alzheimer's Disease and other memory-related cognitive disorders including prion diseases such as Mad Cow Disease. After completion of a Phase II Proof of Concept clinical study in October of 2001 for Phenserine, Axonyx's lead product for Alzh...

GeneTel Laboratories

GeneTel Laboratories provides quality research reagents, lab plastic wares, antibody products and high-throughput proteomic antibody production services to the global life science research and biotech as well as pharmaceutical industries. The company combines high quality custom services with large-scale generation of antibodies against deduced peptides of gene and gene segments from the genome pr...

CompleGen

We are an early stage biopharmaceutical company that is applying a proprietary system to discover novel biologically active chemicals.Our system is used to build compound discovery systems for a broad range of therapeutic targets for the pharmaceutical industry, as well as efficient cost-effective product discovery systems for the agricultural industry. We have discovered, developed, and patented ...

Neuro-Hitech

Neuro-Hitech is focused specifically on the development and commercialization of next-generation therapies against proven targets for neurodegenerative diseases. The company’s signature offering, Huperzine A is being tested for efficacy in the treatment of Alzheimer's disease and the company has plans to study other degenerative disorders such as vascular dementia, mild cognitive impairment and ...

Gene Therapy Systems (GTS)

Gene Therapy Systems, Inc. (GTS) designs, develops and commercializes gene therapy products along with other molecular biological reagents for scientists specializing in gene therapy research. GTS is the only company in the biotechnology reagent business that primarily focuses on gene therapy related products.

Target Health Inc. & LifeOnKey Inc.

Target Health, (www.targethealth.com) established in 1993, is a full service eCRO with full-time staff dedicated to all aspects of drug and device development. Areas of expertise include Regulatory Affairs, strategic planning, IND, IDE, eCTD NDA, PMA and 510(k) submissions, Clinical Trial Monitoring and Project Management, Biostatistics, Data Management, E...

Welgen Incorporation

Welgen, Inc. was founded in 2002 to provide the fastest, most reliable technology available for the construction of recombinant adenoviruses and other research tools. We are currently located in a facility managed by the Massachusetts Biomedical Initiative to foster the development of new biotechnology companies in Massachusetts. We are located in Worcester, the second largest city in New England,...

Arizona Alzheimer's Consortium

The Arizona Alzheimer's Consortium is a laboratory without walls designed to leverage the strengths of its seven member institutions to promote the scientific understanding of Alzheimer's disease. The Consortium is attacking Alzheimer's disease by combining breakthroughs in genomic medicine and cutting-edge research with data from sophisticated brain imaging programs and advanced clinical trials t...


More From BioPortfolio on "Gene Study Yields Possible Alzheimer Target"

Quick Search

Corporate Database Quicklinks